T, S., N, T., K, K., H, U., M, O., S, Y., . . . Y, S. (2025). Corrigendum to "Supportive Evidence of Surrogate End Points Based on Treatment Effect of Corticosteroid in IgA Nephropathy" [Kidney International Reports Volume 11, Issue 2, 2026, Article 103588]. Kidney international reports, 11(2), 103716. https://doi.org/10.1016/j.ekir.2025.103716
Chicago Style (17th ed.) CitationT, Sasaki, et al. "Corrigendum to "Supportive Evidence of Surrogate End Points Based on Treatment Effect of Corticosteroid in IgA Nephropathy" [Kidney International Reports Volume 11, Issue 2, 2026, Article 103588]." Kidney International Reports 11, no. 2 (2025): 103716. https://doi.org/10.1016/j.ekir.2025.103716.
MLA (9th ed.) CitationT, Sasaki, et al. "Corrigendum to "Supportive Evidence of Surrogate End Points Based on Treatment Effect of Corticosteroid in IgA Nephropathy" [Kidney International Reports Volume 11, Issue 2, 2026, Article 103588]." Kidney International Reports, vol. 11, no. 2, 2025, p. 103716, https://doi.org/10.1016/j.ekir.2025.103716.